相似文献
1
Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.
World J Gastroenterol. 2014 Oct 28;20(40):14527-36. doi: 10.3748/wjg.v20.i40.14527.
2
Optimum duration of regimens for Helicobacter pylori eradication.
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.
3
Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors for First-Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta-Analysis.
Helicobacter. 2024 Nov-Dec;29(6):e13150. doi: 10.1111/hel.13150.
4
Helicobacter pylori and gastric or duodenal ulcer.
Prescrire Int. 2016 Jan;25(167):18-23.
5
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
6
Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
J Antimicrob Chemother. 2016 Oct;71(10):2740-53. doi: 10.1093/jac/dkw220. Epub 2016 Jun 23.
7
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5.
8
Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD009034. doi: 10.1002/14651858.CD009034.pub2.
9
Efficacy of second-line regimens for eradication treatment: a systemic review and network meta-analysis.
BMJ Open Gastroenterol. 2020 Sep;7(1). doi: 10.1136/bmjgast-2020-000472.
10
Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy for -positive peptic ulcers: a systematic review and network meta-analysis.
BMJ Open. 2024 Apr 29;14(4):e074188. doi: 10.1136/bmjopen-2023-074188.
引用本文的文献
1
Efficacy and safety of Qingwei Zhitong pellets-containing quadruple therapy for eradication: a prospective, single-center, randomized trial.
J Tradit Chin Med. 2025 Apr;45(2):430-436. doi: 10.19852/j.cnki.jtcm.2025.02.021.
2
The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence.
J Antimicrob Chemother. 2024 Mar 1;79(3):608-616. doi: 10.1093/jac/dkae012.
3
Efficiency and Mechanism Evaluation of Water Extract in Preventing Gastric Ulcer.
Evid Based Complement Alternat Med. 2023 Apr 6;2023:7901734. doi: 10.1155/2023/7901734. eCollection 2023.
4
Ménétrier's Disease and Its Atypical Presentation in Four Siblings.
Cureus. 2022 Oct 27;14(10):e30759. doi: 10.7759/cureus.30759. eCollection 2022 Oct.
5
Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Helicobacter. 2022 Dec;27(6):e12932. doi: 10.1111/hel.12932. Epub 2022 Sep 15.
6
Clinical experience of use of C-breath tests in oesophagogastroduodenal diseases: selective questions.
Prz Gastroenterol. 2020;15(2):126-130. doi: 10.5114/pg.2019.90080. Epub 2019 Dec 1.
7
Antibiotic treatment for Helicobacter pylori: Is the end coming?
World J Gastrointest Pharmacol Ther. 2015 Nov 6;6(4):183-98. doi: 10.4292/wjgpt.v6.i4.183.
本文引用的文献
1
Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment.
BMC Complement Altern Med. 2013 May 30;13:119. doi: 10.1186/1472-6882-13-119.
2
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
JAMA. 2013 Feb 13;309(6):578-86. doi: 10.1001/jama.2013.311.
3
In vitro bactericidal activity of Jinghua Weikang Capsule and its individual herb Chenopodium ambrosioides L. against antibiotic-resistant Helicobacter pylori.
Chin J Integr Med. 2013 Jan;19(1):54-7. doi: 10.1007/s11655-012-1248-y. Epub 2012 Dec 29.
4
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Lancet. 2013 Jan 19;381(9862):205-13. doi: 10.1016/S0140-6736(12)61579-7. Epub 2012 Nov 16.
5
Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
Aliment Pharmacol Ther. 2012 Sep;36(6):534-41. doi: 10.1111/j.1365-2036.2012.05229.x. Epub 2012 Jul 25.
6
Systematic review: hypomagnesaemia induced by proton pump inhibition.
Aliment Pharmacol Ther. 2012 Sep;36(5):405-13. doi: 10.1111/j.1365-2036.2012.05201.x. Epub 2012 Jul 4.
7
Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24.
8
Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.
9
Evaluation of antiulcer activity of chromanone fraction from Calophyllum brasiliesnse Camb.
J Ethnopharmacol. 2012 May 7;141(1):432-9. doi: 10.1016/j.jep.2012.03.006. Epub 2012 Mar 15.
10
Probiotics for maintenance of remission in ulcerative colitis.
Cochrane Database Syst Rev. 2011 Dec 7(12):CD007443. doi: 10.1002/14651858.CD007443.pub2.
Zotero 插件